Non-steroidal anti-inflammatory drugs potentiate the vasoconstrictor effects of ouabain in the dog.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D005227:Fatty Acids / Q000378:metabolism*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D010042:Ouabain / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D013152:Splanchnic Circulation / Q000187:drug effects; D013256:Steroids / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D005227:Fatty Acids; D013256:Steroids; D010042:Ouabain